Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 3/2014

01-06-2014 | CIRSE Standards of Practice Guidelines

Standards of Practice for Superficial Femoral and Popliteal Artery Angioplasty and Stenting

Authors: Konstantinos Katsanos, Gunnar Tepe, Dimitris Tsetis, Fabrizio Fanelli

Published in: CardioVascular and Interventional Radiology | Issue 3/2014

Login to get access

Abstract

This is a Standards of Practice document endorsed by CIRSE. The authors performed a literature review and provide recommendations and quality improvement guidelines based on the most recent and highest level of evidence available to date on the field of Superficial Femoral and Popliteal Artery Angioplasty and Stenting. Standards for the use of basic and more advanced endovascular techniques in the femoropopliteal arteries are reported and relevant aspects of case selection, imaging, follow-up, and overall patient management are presented to guide endovascular practice in Europe.
Literature
1.
go back to reference Kasapis C, Gurm HS (2009) Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Curr Cardiol Rev 5(4):296–311PubMedCentralPubMedCrossRef Kasapis C, Gurm HS (2009) Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Curr Cardiol Rev 5(4):296–311PubMedCentralPubMedCrossRef
2.
go back to reference Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31(1 Pt 2):S1–S296PubMed Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31(1 Pt 2):S1–S296PubMed
3.
go back to reference Norgren L, Hiatt WR, Dormandy JA et al (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33(Suppl 1):S1–S75PubMedCrossRef Norgren L, Hiatt WR, Dormandy JA et al (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33(Suppl 1):S1–S75PubMedCrossRef
4.
go back to reference Rooke TW, Hirsch AT, Misra S et al (2011) 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Vasc Surg 54(5):e32–e58PubMedCrossRef Rooke TW, Hirsch AT, Misra S et al (2011) 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Vasc Surg 54(5):e32–e58PubMedCrossRef
5.
go back to reference Tendera M, Aboyans V, Bartelink ML et al (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32(22):2851–2906PubMedCrossRef Tendera M, Aboyans V, Bartelink ML et al (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32(22):2851–2906PubMedCrossRef
6.
go back to reference Tsetis D, Belli AM (2004) Guidelines for stenting in infrainguinal arterial disease. Cardiovasc Intervent Radiol 27(3):198–203PubMedCrossRef Tsetis D, Belli AM (2004) Guidelines for stenting in infrainguinal arterial disease. Cardiovasc Intervent Radiol 27(3):198–203PubMedCrossRef
7.
go back to reference Cassese S, Byrne RA, Ott I et al (2012) Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv 5(4):582–589PubMedCrossRef Cassese S, Byrne RA, Ott I et al (2012) Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv 5(4):582–589PubMedCrossRef
8.
go back to reference Dake MD, Ansel GM, Jaff MR et al (2011) Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 4(5):495–504PubMedCrossRef Dake MD, Ansel GM, Jaff MR et al (2011) Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 4(5):495–504PubMedCrossRef
9.
go back to reference Duda SH, Pusich B, Richter G et al (2002) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106(12):1505–1509PubMedCrossRef Duda SH, Pusich B, Richter G et al (2002) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106(12):1505–1509PubMedCrossRef
10.
go back to reference Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ (2008) Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 19(6):823–832PubMedCrossRef Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ (2008) Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 19(6):823–832PubMedCrossRef
11.
go back to reference Schillinger M, Sabeti S, Loewe C et al (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354(18):1879–1888PubMedCrossRef Schillinger M, Sabeti S, Loewe C et al (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354(18):1879–1888PubMedCrossRef
12.
go back to reference Alonso-Coello P, Bellmunt S, McGorrian C et al (2012) Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e669S–e690SPubMedCentralPubMed Alonso-Coello P, Bellmunt S, McGorrian C et al (2012) Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e669S–e690SPubMedCentralPubMed
14.
go back to reference Pentecost MJ, Criqui MH, Dorros G et al (2003) Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a Special Writing Group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. J Vasc Interv Radiol 14(9 Pt 2):S495–S515PubMedCrossRef Pentecost MJ, Criqui MH, Dorros G et al (2003) Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. A statement for health professionals from a Special Writing Group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association. J Vasc Interv Radiol 14(9 Pt 2):S495–S515PubMedCrossRef
15.
go back to reference Criqui MH, Ninomiya JK, Wingard DL, Ji M, Fronek A (2008) Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol 52(21):1736–1742PubMedCentralPubMedCrossRef Criqui MH, Ninomiya JK, Wingard DL, Ji M, Fronek A (2008) Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol 52(21):1736–1742PubMedCentralPubMedCrossRef
16.
go back to reference Criqui MH, Langer RD, Fronek A et al (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326(6):381–386PubMedCrossRef Criqui MH, Langer RD, Fronek A et al (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326(6):381–386PubMedCrossRef
17.
go back to reference Slovut DP, Sullivan TM (2008) Critical limb ischemia: medical and surgical management. Vasc Med 13(3):281–291PubMedCrossRef Slovut DP, Sullivan TM (2008) Critical limb ischemia: medical and surgical management. Vasc Med 13(3):281–291PubMedCrossRef
18.
go back to reference Karnabatidis D, Spiliopoulos S, Tsetis D, Siablis D (2011) Quality improvement guidelines for percutaneous catheter-directed intra-arterial thrombolysis and mechanical thrombectomy for acute lower-limb ischemia. Cardiovasc Intervent Radiol 34(6):1123–1136PubMedCrossRef Karnabatidis D, Spiliopoulos S, Tsetis D, Siablis D (2011) Quality improvement guidelines for percutaneous catheter-directed intra-arterial thrombolysis and mechanical thrombectomy for acute lower-limb ischemia. Cardiovasc Intervent Radiol 34(6):1123–1136PubMedCrossRef
19.
go back to reference Fowkes FG, Murray GD, Butcher I et al (2008) Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300(2):197–208PubMedCrossRef Fowkes FG, Murray GD, Butcher I et al (2008) Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300(2):197–208PubMedCrossRef
20.
go back to reference Allaqaband S, Kirvaitis R, Jan F, Bajwa T (2009) Endovascular treatment of peripheral vascular disease. Curr Probl Cardiol 34(9):359–476PubMedCrossRef Allaqaband S, Kirvaitis R, Jan F, Bajwa T (2009) Endovascular treatment of peripheral vascular disease. Curr Probl Cardiol 34(9):359–476PubMedCrossRef
21.
go back to reference Ledermann HP, Heidecker HG, Schulte AC et al (2006) Calf muscles imaged at BOLD MR: correlation with TcPO2 and flowmetry measurements during ischemia and reactive hyperemia–initial experience. Radiology 241(2):477–484PubMedCrossRef Ledermann HP, Heidecker HG, Schulte AC et al (2006) Calf muscles imaged at BOLD MR: correlation with TcPO2 and flowmetry measurements during ischemia and reactive hyperemia–initial experience. Radiology 241(2):477–484PubMedCrossRef
22.
go back to reference Ladurner R, Kuper M, Konigsrainer I et al (2010) Predictive value of routine transcutaneous tissue oxygen tension (tcpO2) measurement for the risk of non-healing and amputation in diabetic foot ulcer patients with non-palpable pedal pulses. Med Sci Monit 16(6):CR273–CR277PubMed Ladurner R, Kuper M, Konigsrainer I et al (2010) Predictive value of routine transcutaneous tissue oxygen tension (tcpO2) measurement for the risk of non-healing and amputation in diabetic foot ulcer patients with non-palpable pedal pulses. Med Sci Monit 16(6):CR273–CR277PubMed
23.
go back to reference Girolami B, Bernardi E, Prins MH et al (1999) Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med 159(4):337–345PubMedCrossRef Girolami B, Bernardi E, Prins MH et al (1999) Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med 159(4):337–345PubMedCrossRef
24.
go back to reference Mahmud E, Cavendish JJ, Salami A (2007) Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. J Am Coll Cardiol 50(6):473–490PubMedCrossRef Mahmud E, Cavendish JJ, Salami A (2007) Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. J Am Coll Cardiol 50(6):473–490PubMedCrossRef
25.
go back to reference Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326):7–22CrossRef Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326):7–22CrossRef
26.
go back to reference Altenburg A, Haage P (2012) Antiplatelet and anticoagulant drugs in interventional radiology. Cardiovasc Intervent Radiol 35(1):30–42PubMedCrossRef Altenburg A, Haage P (2012) Antiplatelet and anticoagulant drugs in interventional radiology. Cardiovasc Intervent Radiol 35(1):30–42PubMedCrossRef
27.
go back to reference Antithrombotic Trialists C (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71–86CrossRef Antithrombotic Trialists C (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71–86CrossRef
28.
go back to reference CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348(9038):1329–1339CrossRef CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348(9038):1329–1339CrossRef
29.
go back to reference Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA (2009) Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 30(2):192–201PubMedCrossRef Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA (2009) Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 30(2):192–201PubMedCrossRef
30.
go back to reference Bhatt DL, Flather MD, Hacke W et al (2007) Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 49(19):1982–1988PubMedCrossRef Bhatt DL, Flather MD, Hacke W et al (2007) Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 49(19):1982–1988PubMedCrossRef
31.
go back to reference Girolami B, Bernardi E, Prins MH et al (2000) Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. Eur J Vasc Endovasc Surg 19(4):370–380PubMedCrossRef Girolami B, Bernardi E, Prins MH et al (2000) Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. Eur J Vasc Endovasc Surg 19(4):370–380PubMedCrossRef
32.
go back to reference Hankey GJ, Norman PE, Eikelboom JW (2006) Medical treatment of peripheral arterial disease. JAMA 295(5):547–553PubMedCrossRef Hankey GJ, Norman PE, Eikelboom JW (2006) Medical treatment of peripheral arterial disease. JAMA 295(5):547–553PubMedCrossRef
33.
go back to reference Alexandrescu V, Vincent G, Azdad K et al (2011) A reliable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. J Endovasc Ther 18(3):376–387PubMedCrossRef Alexandrescu V, Vincent G, Azdad K et al (2011) A reliable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. J Endovasc Ther 18(3):376–387PubMedCrossRef
34.
go back to reference Peregrin JH, Koznar B, Kovac J et al (2010) PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol 33(4):720–725PubMedCrossRef Peregrin JH, Koznar B, Kovac J et al (2010) PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol 33(4):720–725PubMedCrossRef
35.
go back to reference Baril DT, Marone LK (2012) Duplex evaluation following femoropopliteal angioplasty and stenting: criteria and utility of surveillance. Vasc Endovasc Surg 46(5):353–357CrossRef Baril DT, Marone LK (2012) Duplex evaluation following femoropopliteal angioplasty and stenting: criteria and utility of surveillance. Vasc Endovasc Surg 46(5):353–357CrossRef
36.
go back to reference Langenberger H, Schillinger M, Plank C et al (2012) Agreement of duplex ultrasonography vs. computed tomography angiography for evaluation of native and in-stent SFA re-stenosis–findings from a randomized controlled trial. Eur J Radiol 81(9):2265–2269PubMedCrossRef Langenberger H, Schillinger M, Plank C et al (2012) Agreement of duplex ultrasonography vs. computed tomography angiography for evaluation of native and in-stent SFA re-stenosis–findings from a randomized controlled trial. Eur J Radiol 81(9):2265–2269PubMedCrossRef
37.
go back to reference Ouwendijk R, de Vries M, Stijnen T et al (2008) Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial. AJR Am J Roentgenol 190(5):1349–1357PubMedCrossRef Ouwendijk R, de Vries M, Stijnen T et al (2008) Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial. AJR Am J Roentgenol 190(5):1349–1357PubMedCrossRef
38.
39.
go back to reference Miyazaki M, Akahane M (2012) Non-contrast enhanced MR angiography: established techniques. J Magn Reson Imaging 35(1):1–19PubMedCrossRef Miyazaki M, Akahane M (2012) Non-contrast enhanced MR angiography: established techniques. J Magn Reson Imaging 35(1):1–19PubMedCrossRef
40.
go back to reference Patel IJ, Davidson JC, Nikolic B et al (2012) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23(6):727–736PubMedCrossRef Patel IJ, Davidson JC, Nikolic B et al (2012) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23(6):727–736PubMedCrossRef
41.
go back to reference Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21(12):2527–2541PubMedCrossRef Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21(12):2527–2541PubMedCrossRef
42.
go back to reference Erselcan T, Egilmez H, Hasbek Z, Tandogan I (2012) Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients. Acta Radiol 53(2):228–232PubMedCrossRef Erselcan T, Egilmez H, Hasbek Z, Tandogan I (2012) Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients. Acta Radiol 53(2):228–232PubMedCrossRef
43.
go back to reference Siablis D, Kraniotis P, Karnabatidis D, Kagadis GC, Katsanos K, Tsolakis J (2005) Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 12(6):685–695PubMedCrossRef Siablis D, Kraniotis P, Karnabatidis D, Kagadis GC, Katsanos K, Tsolakis J (2005) Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 12(6):685–695PubMedCrossRef
44.
go back to reference Gable D (2011) Role of total endoluminal superficial femoral artery bypass. J Cardiovasc Surg (Torino) 52(5):683–700 Gable D (2011) Role of total endoluminal superficial femoral artery bypass. J Cardiovasc Surg (Torino) 52(5):683–700
45.
go back to reference Fanelli F, Lucatelli P, Allegritti M, Corona M, Rossi P, Passariello R (2011) Retrograde popliteal access in the supine patient for recanalization of the superficial femoral artery: initial results. J Endovasc Ther 18(4):503–509PubMedCrossRef Fanelli F, Lucatelli P, Allegritti M, Corona M, Rossi P, Passariello R (2011) Retrograde popliteal access in the supine patient for recanalization of the superficial femoral artery: initial results. J Endovasc Ther 18(4):503–509PubMedCrossRef
46.
go back to reference Gandini R, Fabiano S, Spano S et al (2012) Randomized control study of the outback ltd re-entry catheter vs. manual re-entry for the treatment of chronic total occlusions in the superficial femoral artery. Catheter Cardiovasc Interv 82(3):485–492CrossRef Gandini R, Fabiano S, Spano S et al (2012) Randomized control study of the outback ltd re-entry catheter vs. manual re-entry for the treatment of chronic total occlusions in the superficial femoral artery. Catheter Cardiovasc Interv 82(3):485–492CrossRef
47.
go back to reference Gutzeit A, Graf N, Schoch E, Sautter T, Jenelten R, Binkert CA (2011) Ultrasound-guided antegrade femoral access: comparison between the common femoral artery and the superficial femoral artery. Eur Radiol 21(6):1323–1328PubMedCrossRef Gutzeit A, Graf N, Schoch E, Sautter T, Jenelten R, Binkert CA (2011) Ultrasound-guided antegrade femoral access: comparison between the common femoral artery and the superficial femoral artery. Eur Radiol 21(6):1323–1328PubMedCrossRef
48.
go back to reference Bown MJ, Bolia A, Sutton AJ (2009) Subintimal angioplasty: meta-analytical evidence of clinical utility. Eur J Vasc Endovasc Surg 38(3):323–337PubMedCrossRef Bown MJ, Bolia A, Sutton AJ (2009) Subintimal angioplasty: meta-analytical evidence of clinical utility. Eur J Vasc Endovasc Surg 38(3):323–337PubMedCrossRef
49.
go back to reference Bolia A, Brennan J, Bell PR (1989) Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol 40(3):325PubMedCrossRef Bolia A, Brennan J, Bell PR (1989) Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol 40(3):325PubMedCrossRef
50.
go back to reference Siablis D, Diamantopoulos A, Katsanos K et al (2012) Subintimal angioplasty of long chronic total femoropopliteal occlusions: long-term outcomes, predictors of angiographic restenosis, and role of stenting. Cardiovasc Intervent Radiol 35(3):483–490PubMedCrossRef Siablis D, Diamantopoulos A, Katsanos K et al (2012) Subintimal angioplasty of long chronic total femoropopliteal occlusions: long-term outcomes, predictors of angiographic restenosis, and role of stenting. Cardiovasc Intervent Radiol 35(3):483–490PubMedCrossRef
51.
go back to reference Dick P, Wallner H, Sabeti S et al (2009) Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 74(7):1090–1095PubMedCrossRef Dick P, Wallner H, Sabeti S et al (2009) Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 74(7):1090–1095PubMedCrossRef
52.
go back to reference Krankenberg H, Schluter M, Steinkamp HJ et al (2007) Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116(3):285–292PubMedCrossRef Krankenberg H, Schluter M, Steinkamp HJ et al (2007) Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116(3):285–292PubMedCrossRef
53.
go back to reference Chalmers N, Walker PT, Belli AM, Thorpe AP, Sidhu PS, Robinson G, van Ransbeeck M, Fearn SA (2013) Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study. Cardiovasc Intervent Radiol 36(2):353–361 Chalmers N, Walker PT, Belli AM, Thorpe AP, Sidhu PS, Robinson G, van Ransbeeck M, Fearn SA (2013) Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study. Cardiovasc Intervent Radiol 36(2):353–361
54.
go back to reference Perrio S, Holt PJ, Patterson BO, Hinchliffe RJ, Loftus IM, Thompson MM (2010) Role of superficial femoral artery stents in the management of arterial occlusive disease: review of current evidence. Vascular 18(2):82–92PubMedCrossRef Perrio S, Holt PJ, Patterson BO, Hinchliffe RJ, Loftus IM, Thompson MM (2010) Role of superficial femoral artery stents in the management of arterial occlusive disease: review of current evidence. Vascular 18(2):82–92PubMedCrossRef
55.
go back to reference Kasapis C, Henke PK, Chetcuti SJ et al (2009) Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 30(1):44–55PubMedCrossRef Kasapis C, Henke PK, Chetcuti SJ et al (2009) Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 30(1):44–55PubMedCrossRef
56.
go back to reference Shammas NW, Coiner D, Shammas G, Jerin M (2011) Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. Int J Angiol 20(2):95–100PubMedCentralPubMedCrossRef Shammas NW, Coiner D, Shammas G, Jerin M (2011) Predictors of provisional stenting in patients undergoing lower extremity arterial interventions. Int J Angiol 20(2):95–100PubMedCentralPubMedCrossRef
57.
go back to reference Rits J, van Herwaarden JA, Jahrome AK, Krievins D, Moll FL (2008) The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings. Eur J Vasc Endovasc Surg 36(3):339–345PubMedCrossRef Rits J, van Herwaarden JA, Jahrome AK, Krievins D, Moll FL (2008) The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings. Eur J Vasc Endovasc Surg 36(3):339–345PubMedCrossRef
58.
go back to reference Scheinert D, Scheinert S, Sax J et al (2005) Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45(2):312–315PubMedCrossRef Scheinert D, Scheinert S, Sax J et al (2005) Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45(2):312–315PubMedCrossRef
59.
go back to reference Richter GM, Palmaz JC, Noeldge G, Tio F (1999) Relationship between blood flow, thrombus, and neointima in stents. J Vasc Interv Radiol 10(5):598–604PubMedCrossRef Richter GM, Palmaz JC, Noeldge G, Tio F (1999) Relationship between blood flow, thrombus, and neointima in stents. J Vasc Interv Radiol 10(5):598–604PubMedCrossRef
60.
go back to reference Wainwright CL, Miller AM, Wadsworth RM (2001) Inflammation as a key event in the development of neointima following vascular balloon injury. Clin Exp Pharmacol Physiol 28(11):891–895PubMedCrossRef Wainwright CL, Miller AM, Wadsworth RM (2001) Inflammation as a key event in the development of neointima following vascular balloon injury. Clin Exp Pharmacol Physiol 28(11):891–895PubMedCrossRef
61.
go back to reference Bhoday J, de Silva S, Xu Q (2006) The molecular mechanisms of vascular restenosis: which genes are crucial? Curr Vasc Pharmacol 4(3):269–275PubMedCrossRef Bhoday J, de Silva S, Xu Q (2006) The molecular mechanisms of vascular restenosis: which genes are crucial? Curr Vasc Pharmacol 4(3):269–275PubMedCrossRef
62.
go back to reference Schwartz RS, Huber KC, Murphy JG et al (1992) Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 19(2):267–274PubMedCrossRef Schwartz RS, Huber KC, Murphy JG et al (1992) Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 19(2):267–274PubMedCrossRef
63.
go back to reference Duda SH, Bosiers M, Lammer J et al (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16(3):331–338PubMedCrossRef Duda SH, Bosiers M, Lammer J et al (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16(3):331–338PubMedCrossRef
64.
go back to reference Cioppa A, Stabile E, Popusoi G et al (2012) Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: one-year single centre clinical results. Cardiovasc Revasc Med 13(4):219–223PubMedCrossRef Cioppa A, Stabile E, Popusoi G et al (2012) Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: one-year single centre clinical results. Cardiovasc Revasc Med 13(4):219–223PubMedCrossRef
65.
go back to reference Zeller T, Krankenberg H, Steinkamp H et al (2009) One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther 16(6):653–662PubMedCrossRef Zeller T, Krankenberg H, Steinkamp H et al (2009) One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther 16(6):653–662PubMedCrossRef
66.
go back to reference Khaghany K, Al-Ali F, Spigelmoyer T, Pimentel R, Wharton K (2005) Efficacy and safety of the perclose closer s device after neurointerventional procedures: prospective study and literature review. AJNR Am J Neuroradiol 26(6):1420–1424PubMed Khaghany K, Al-Ali F, Spigelmoyer T, Pimentel R, Wharton K (2005) Efficacy and safety of the perclose closer s device after neurointerventional procedures: prospective study and literature review. AJNR Am J Neuroradiol 26(6):1420–1424PubMed
67.
go back to reference Upponi SS, Ganeshan AG, Warakaulle DR, Phillips-Hughes J, Boardman P, Uberoi R (2007) Angioseal versus manual compression for haemostasis following peripheral vascular diagnostic and interventional procedures–a randomized controlled trial. Eur J Radiol 61(2):332–334PubMedCrossRef Upponi SS, Ganeshan AG, Warakaulle DR, Phillips-Hughes J, Boardman P, Uberoi R (2007) Angioseal versus manual compression for haemostasis following peripheral vascular diagnostic and interventional procedures–a randomized controlled trial. Eur J Radiol 61(2):332–334PubMedCrossRef
68.
go back to reference Zalunardo B, Tonello D, Busato F, Zotta L, Irsara S, Visona A (2012) Antithrombotic therapy after peripheral angioplasty, various techniques and challenges in treatment of congenital and acquired vascular stenoses, Dr. Thomas Forbes (Ed.), ISBN: 978-953-51-0084-3, InTech Zalunardo B, Tonello D, Busato F, Zotta L, Irsara S, Visona A (2012) Antithrombotic therapy after peripheral angioplasty, various techniques and challenges in treatment of congenital and acquired vascular stenoses, Dr. Thomas Forbes (Ed.), ISBN: 978-953-51-0084-3, InTech
69.
go back to reference Tepe G, Bantleon R, Brechtel K et al (2012) Management of peripheral arterial interventions with mono or dual antiplatelet therapy—the MIRROR study: a randomised and double-blinded clinical trial. Eur Radiol 22(9):1998–2006PubMedCrossRef Tepe G, Bantleon R, Brechtel K et al (2012) Management of peripheral arterial interventions with mono or dual antiplatelet therapy—the MIRROR study: a randomised and double-blinded clinical trial. Eur Radiol 22(9):1998–2006PubMedCrossRef
70.
go back to reference Spiliopoulos S, Pastromas G, Katsanos K, Kitrou P, Karnabatidis D, Siablis D (2013) Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP Study: Clinical Impact and Optimal Cutoff Value of On-Treatment High Platelet Reactivity. J Am Coll Cardiol 61(24):2428–2434PubMedCrossRef Spiliopoulos S, Pastromas G, Katsanos K, Kitrou P, Karnabatidis D, Siablis D (2013) Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP Study: Clinical Impact and Optimal Cutoff Value of On-Treatment High Platelet Reactivity. J Am Coll Cardiol 61(24):2428–2434PubMedCrossRef
71.
go back to reference Muradin GS, Bosch JL, Stijnen T, Hunink MG (2001) Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 221(1):137–145PubMedCrossRef Muradin GS, Bosch JL, Stijnen T, Hunink MG (2001) Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 221(1):137–145PubMedCrossRef
72.
go back to reference Acin F, de Haro J, Bleda S, Varela C, Esparza L (2012) Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. J Endovasc Ther 19(5):585–595PubMedCrossRef Acin F, de Haro J, Bleda S, Varela C, Esparza L (2012) Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. J Endovasc Ther 19(5):585–595PubMedCrossRef
73.
go back to reference Duda SH, Bosiers M, Lammer J et al (2006) Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13(6):701–710PubMedCrossRef Duda SH, Bosiers M, Lammer J et al (2006) Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 13(6):701–710PubMedCrossRef
74.
go back to reference Spiliopoulos S, Katsanos K, Karnabatidis D et al (2010) Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients: long-term results from a prospective randomized single-center controlled trial. Cardiovasc Intervent Radiol 33(5):929–938PubMedCrossRef Spiliopoulos S, Katsanos K, Karnabatidis D et al (2010) Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients: long-term results from a prospective randomized single-center controlled trial. Cardiovasc Intervent Radiol 33(5):929–938PubMedCrossRef
75.
go back to reference Samson RH, Showalter DP, Lepore M Jr, Nair DG, Merigliano K (2008) CryoPlasty therapy of the superficial femoral and popliteal arteries: a reappraisal after 44 months’ experience. J Vasc Surg 48(3):634–637PubMedCrossRef Samson RH, Showalter DP, Lepore M Jr, Nair DG, Merigliano K (2008) CryoPlasty therapy of the superficial femoral and popliteal arteries: a reappraisal after 44 months’ experience. J Vasc Surg 48(3):634–637PubMedCrossRef
76.
go back to reference Axisa B, Fishwick G, Bolia A et al (2002) Complications following peripheral angioplasty. Ann R Coll Surg Engl 84(1):39–42PubMedCentralPubMed Axisa B, Fishwick G, Bolia A et al (2002) Complications following peripheral angioplasty. Ann R Coll Surg Engl 84(1):39–42PubMedCentralPubMed
77.
go back to reference Kearns BC, Michaels JA, Stevenson MD, Thomas SM (2013) Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease. Br J Surg 100(9):1180–1188PubMedCrossRef Kearns BC, Michaels JA, Stevenson MD, Thomas SM (2013) Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease. Br J Surg 100(9):1180–1188PubMedCrossRef
78.
79.
go back to reference Owen AR, Roditi GH (2011) Peripheral arterial disease: the evolving role of non-invasive imaging. Postgrad Med J 87(1025):189–198PubMedCrossRef Owen AR, Roditi GH (2011) Peripheral arterial disease: the evolving role of non-invasive imaging. Postgrad Med J 87(1025):189–198PubMedCrossRef
80.
go back to reference Sacks D, Marinelli DL, Martin LG, Spies JB (1997) Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. Technology Assessment Committee. J Vasc Interv Radiol 8(1 Pt 1):137–149PubMedCrossRef Sacks D, Marinelli DL, Martin LG, Spies JB (1997) Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. Technology Assessment Committee. J Vasc Interv Radiol 8(1 Pt 1):137–149PubMedCrossRef
81.
go back to reference Karnabatidis D, Katsanos K, Kagadis GC et al (2006) Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: an underestimated phenomenon. J Endovasc Ther 13(3):269–280PubMedCrossRef Karnabatidis D, Katsanos K, Kagadis GC et al (2006) Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: an underestimated phenomenon. J Endovasc Ther 13(3):269–280PubMedCrossRef
Metadata
Title
Standards of Practice for Superficial Femoral and Popliteal Artery Angioplasty and Stenting
Authors
Konstantinos Katsanos
Gunnar Tepe
Dimitris Tsetis
Fabrizio Fanelli
Publication date
01-06-2014
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 3/2014
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-014-0876-3

Other articles of this Issue 3/2014

CardioVascular and Interventional Radiology 3/2014 Go to the issue